SEARCH RESULTS

121 RESULTS

Where to Turn for Research: Human Studies of eFAD

Other Massachusetts General Hospital, Boston Summary This institution has an ongoing eFAD imaging study that aims to understand how the appearance of amyloid relates to changes in brain function. The study welcomes carriers of eFAD mutations and their ...

Where to Turn for Research: Human Studies of eFAD

Other University of Pittsburgh, PA Summary This is an ongoing study funded by the National Institute of Aging and private funding. It documents the natural history of amyloid deposition in presymptomatic carriers and other relatives of families with eFAD. It is ...

Where to Turn for Research: Human Studies of eFAD

Other University of California, Los Angeles Summary At-risk relatives in families with FAD are invited to come to the clinical research center (CRC) of UCLA for a 4-5-day evaluation. Both carriers and non-carriers are needed for comparison. One goal of this ...

Where to Turn for Research: Human Studies of eFAD

Other Washington University, St. Louis, Missouri Summary The Familial Adult Children Study (FACS) is an observational study to observe the presymptomatic stages of disease development. It invites all adult volunteers in families who have an autosomal-dominant ...

Diagnosis

Other Important Notice:  The Alzheimer Research Forum does not provide medical advice. The contents are for informational purposes only and are not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a ...

Q&A with Richard Bozanich

Other Questions by Gabrielle Strobel Richard Bozanich, 50, has early onset dementia, Probable Alzheimer's Type. During his career, Bozanich was a journalist who wrote and/or edited for the Harvard Business School, the Los Angeles Times, the Dallas Morning ...

Interview: One Man's Forward Approach

Other Thomas Greene's mother developed AD in her mid-thirties. Thomas decided to end uncertainty about his own genetic status and took a predictive test when he was 31. When it came back positive for an AD mutation, he grabbed the bull by its horns as best ...

Interview with Jennifer Williamson

Other By Gabrielle Strobel Jennifer Williamson is a genetic counselor at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H. Sergievsky Center at Columbia University, New York. She sees families with neurogenetic ...

NPR Audio Interviews with Thomas Debaggio

Other When he was 55, herb farmer Tom DeBaggio, called the "Best Rosemaryologist in the country," began to notice problems with his memory. Working the checkout register of his family business, he could not name plants he'd been growing for ...

Where to Turn for Research: Human Studies of eFAD

Other By Gabrielle Strobel Editor's note:  For definitions of early onset Alzheimer disease (EOAD) and early onset familial Alzheimer disease (eFAD), please see our essay, What Is Early Onset Familial Alzheimer Disease (eFAD)? Families with eFAD who are ...

Prevention With Statins: Can the Brain Learn From the Heart?

Other By Gabrielle Strobel Cholesterol-lowering statin drugs give people with high blood cholesterol a fair shot at averting a future heart attack. Patients and their doctors across the country got to this place through a 20-year-long series of treatment and ...

Devil in the Details—The Challenges of Prevention Trials

Other By Gabrielle Strobel Companies have not yet tried to repeat the statin story in Alzheimer disease. You cannot simply make a carbon copy of a successful drug development strategy, they say, and once you start thinking about the particulars of AD, tricky ...

Prevention—Do eFAD Families Hold the Key?

Other By Gabrielle Strobel Editor's note:  For definitions of early onset familial Alzheimer disease (eFAD), early onset AD (EOAD), and late-onset AD (LOAD), please visit  What Is Early Onset Familial Alzheimer Disease. Historically, people with early ...

Interview: A Spouse's Perspective on Clinical Trials for eFAD

Other In this conversation with Gabrielle Strobel, the husband of a 39-year-old woman with early onset familial AD (eFAD) discusses the uncharted territory of clinical trials for eFAD patients. All names are pseudonyms. See our previous interview with this ...

Drug Trials in Early Onset AD

Other By Gabrielle Strobel In the world of drug testing, there are a number of different avenues by which people with eFAD and EOAD could contribute to the goal of therapy development and in the process hope to obtain access to up-to-date care. Each has its ...

Current Filters

  • TYPE: Other x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE